scholarly article | Q13442814 |
P50 | author | Ralf Dechend | Q63812628 |
P2093 | author name string | Michael J Ryan | |
James N Martin | |||
Marc R Parrish | |||
Justin Brewer | |||
Porter Glover | |||
Babbette B Lamarca | |||
Lillian Ray | |||
P2860 | cites work | Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 |
Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy | Q34182166 | ||
Recent Insights into the pathogenesis of pre-eclampsia | Q34682287 | ||
Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia | Q35681821 | ||
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice | Q35701236 | ||
Activating auto-antibodies against the AT1 receptor in preeclampsia | Q36010629 | ||
Role of the renin-angiotensin system in the pathogenesis of preeclampsia | Q36064478 | ||
Role of sex steroids in modulating tumor necrosis factor alpha-induced changes in vascular function and blood pressure | Q36168798 | ||
Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia | Q36380482 | ||
Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade | Q37459545 | ||
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women | Q45158743 | ||
Vascular ENaC proteins are required for renal myogenic constriction | Q46508494 | ||
Renal vascular responses to CORM-A1 in the mouse | Q46981113 | ||
Implication of an AGT haplotype in a multigene association study with pregnancy hypertension | Q47364068 | ||
Dysregulation of the Circulating and Tissue-Based Renin-Angiotensin System in Preeclampsia | Q56981959 | ||
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
P433 | issue | 3 | |
P921 | main subject | endothelium | Q111140 |
autoantibody | Q785022 | ||
P304 | page(s) | 184-188 | |
P577 | publication date | 2011-05-20 | |
P1433 | published in | Gender Medicine | Q15816303 |
P1476 | title | Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | |
P478 | volume | 8 |
Q38126570 | A complicated role for the renin-angiotensin system during pregnancy: highlighting the importance of drug discovery |
Q37507162 | Administration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancy |
Q33983807 | Advances in the pathophysiology of pre-eclampsia and related podocyte injury |
Q36355165 | Agonistic autoantibodies to the angiotensin II type I receptor cause pathophysiologic characteristics of preeclampsia |
Q36339336 | An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia |
Q37353499 | Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension |
Q27027039 | Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond |
Q34040357 | Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia |
Q36339273 | Blockade of CD40 ligand for intercellular communication reduces hypertension, placental oxidative stress, and AT1-AA in response to adoptive transfer of CD4+ T lymphocytes from RUPP rats |
Q26852668 | Elucidating immune mechanisms causing hypertension during pregnancy |
Q37229246 | Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia |
Q36115279 | Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system. |
Q36997267 | IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia |
Q36178540 | IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy |
Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
Q58589187 | Molecular Determinants of Microvascular Dysfunction in Hypertensive Pregnancy and Preeclampsia |
Q37451544 | Placental Ischemia and Resultant Phenotype in Animal Models of Preeclampsia |
Q28395340 | Pregnant rats treated with a high-fat/prooxidant Western diet with ANG II and TNF-α are resistant to elevations in blood pressure and renal oxidative stress |
Q38691672 | Proliferation of endogenous regulatory T cells improve the pathophysiology associated with placental ischaemia of pregnancy |
Q39136791 | Recent Advances in Immunity and Hypertension |
Q35707881 | Receptor-activating autoantibodies and disease: preeclampsia and beyond |
Q45848306 | Reduced uterine perfusion pressure T-helper 17 cells cause pathophysiology associated with preeclampsia during pregnancy |
Q47577568 | The agonistic autoantibodies to the angiotensin II type 1 receptor in pregnancies complicated by hypertensive disorders |
Q57150158 | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia |
Q33834419 | The role of inflammation in the pathology of preeclampsia |
Q36309225 | Timing of ischemic insult alters fetal growth trajectory, maternal angiogenic balance, and markers of renal oxidative stress in the pregnant rat. |
Q38116097 | Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis. |
Q38124456 | Vascular dysfunction in preeclampsia |
Q36699839 | Vitamin D supplementation improves pathophysiology in a rat model of preeclampsia |
Search more.